-
Today’s Hot List: Heat Biologics (NASDAQ:HTBX), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Wal-Mart Stores Inc. (NYSE:WMT), JetBlue Airways Corporation (NASDAQ:JBLU), Zoe’s Kitchen (NYSE:ZOES)
On Monday shares of Heat Biologics, Inc. (NASDAQ:HTBX) closed at $5.75. On May 11, Heat Biologics, Inc. (NASDAQ:HTBX), announced that it has enrolled the first patient in a new Phase 1b trial of Viagenpumatucel-L (HS-110) in patients with non-small cell lung cancer (“NSCLC”). This new trial enables Heat to combine its HS-110 with multiple immune…
-
Top Wall Street Stories: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Express Scripts Holding (NASDAQ:ESRX), The Brink’s (NYSE:BCO), Fortress Investment Group (NYSE:FIG), General Motors (NYSE:GM)
On Tuesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $8.95. Company’s sales growth for last 5 years was 3.60%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced that it hosted a Key Opinion Leader (KOL) breakfast in New York City focused on offering insights into the evolution of the U.S. regulatory landscape, along with a clinician’s perspective…
-
Top Wall Street Stories: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Applied Materials (NASDAQ:AMAT), Cover-All Technologies Inc. (NYSEMKT:COVR), Extreme Networks (NASDAQ:EXTR), CIFC Corp. (NASDAQ:CIFC)
On Tuesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $9.25. Company’s sales growth for last 5 years was 3.60%. EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS) announced financial results for the fourth quarter and fiscal year ended December 31, 2014. Research and Development (R&D) expenses were $4.8 million for the fourth quarter of 2014 compared to $2.4…
-
Stocks to Watch: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Delta Air Lines (NYSE:DAL), Bank of America (NYSE:BAC), Hovnanian Enterprises (NYSE:HOV), Varian Medical Systems (NYSE:VAR)
On Tuesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $9.51. EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), announced that it will host a conference call and webcast at 10 a.m. Eastern Time on Tuesday, March 24, 2015 to discuss fourth quarter and fiscal year 2014 financial results, and to discuss the Company’s progress. The call will be…
-
Stock in News: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), SodaStream International (NASDAQ:SODA), Cablevision Systems Corporation (NYSE:CVC), MannKind Corp. (NASDAQ:MNKD), Ballard Power Systems (NASDAQ:BLDP)
Wedbush assumed coverage on shares of Epirus Biopharmaceuticals (NASDAQ:EPRS) in a report released on Wednesday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $10.36. Company’s sales growth for last 5 years was 3.60%. SodaStream International Ltd. (NASDAQ:…
-
Active Movers: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), ZIOPHARM Oncology (NASDAQ:ZIOP), British American Tobacco plc (NYSEMKT:BTI), CaesarStone Sdot-Yam (NASDAQ:CSTE), Natural Grocers (NYSE:NGVC)
On 30 January, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced the pricing of an underwritten public offering of 9.6 million shares of its common stock, offered at a price to the public of $5.00 per share. On Thursday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $7.00. Company’s sales growth for last 5 years was 3.60%. ZIOPHARM…
-
Top News: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), LoJack Corporation (NASDAQ:LOJN), General Electric Company (NYSE:GE), Diebold, Incorporated (NYSE:DBD), Applied Industrial Technologies (NYSE:AIT)
On January 30, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) announced the pricing of an underwritten public offering of 9.6 million shares of its common stock, offered at a price to the public of $5.00 per share. On Wednesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $5.89. Company’s sales growth for last 5 years was 3.60%. On…
-
Why These Are Hot: GlobalSCAPE (NYSEMKT:GSB), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Iteris (NYSEMKT:ITI), Amedica (NASDAQ:AMDA), Biocept (NASDAQ:BIOC)
On 5 February, GlobalSCAPE, Inc. (NYSEMKT: GSB) announced the initiation of a quarterly cash dividend program commencing the second quarter of 2015. The initial cash dividend will be $0.015 per share with the applicable second quarter record and payment dates to be determined. On Tuesday shares of GlobalSCAPE, Inc. (NYSEMKT: GSB) closed at $3.06. Company’s…
-
Biotech Volatile Stocks: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Kite Pharma (NASDAQ:KITE), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Ohr Pharmaceutical (NASDAQ:OHRP), Cellular Biomedicine (NASDAQ:CBMG)
On 5 February, RXi Pharmaceuticals Corporation (NASDAQ: RXII), announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone™ with Hapten Pharmaceuticals, LLC. On Tuesday shares of RXi Pharmaceuticals Corporation (NASDAQ:RXII) closed at $1.26. On 3 February, Kite Pharma, Inc., (NASDAQ:KITE) announced the appointments of Salah D. Kivlighn, Ph.D.,…